Strength

20; 5 mg/mL; mg/mL

NDC

62332055310

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA213099

On Market Since

5/4/2021

Pharmacological Classes

Adrenergic beta-Antagonists
Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors
beta-Adrenergic Blocker

Price History

1W

0.0%

1M

-1.0%

3M

-1.0%

6M

-6.7%

1Y

N/A

3Y

N/A

5Y

N/A

All

-19.3%